Research Triangle Park, North Carolina Saturday, February 15, 2025, 17:00 Hrs [IST] ...

Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for older heart patients.

Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...

The actress has been supporting calls for greater awareness of heart failure, which, according to the PHA, is a complex ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Heart transplants are complex, costly, and risky—but for patients with heart failure, they are often the only option for ...

Infection-related hospitalization (IRH) is associated with incident heart failure, heart failure with preserved ejection ...

After surviving a life-threatening heart infection and undergoing emergency surgery, an Ontario man is celebrating both his recovery and his birthday on Valentine’s Day.

New research explores how point-of-care lung ultrasound can improve prehospital identification of acute heart failure ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

Women are often underdiagnosed and undertreated when it comes to heart disease, particularly conditions like aortic stenosis.